{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:56:02Z","timestamp":1767923762783,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T00:00:00Z","timestamp":1469404800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00105-016-3844-9","type":"journal-article","created":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T13:13:25Z","timestamp":1469452405000},"page":"724-731","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Terbinafin","Terbinafine"],"prefix":"10.1007","volume":"67","author":[{"given":"P.","family":"Mayser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,25]]},"reference":[{"issue":"3","key":"3844_CR1","first-page":"415","volume":"145","author":"C Gianni","year":"2010","unstructured":"Gianni C (2010) Update on antifungal therapy with terbinafine. G Ital Dermatol Venereol 145(3):415\u2013424","journal-title":"G Ital Dermatol Venereol"},{"issue":"16","key":"3844_CR2","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1517\/14656560903307462","volume":"10","author":"S Krishnan-Natesan","year":"2009","unstructured":"Krishnan-Natesan S (2009) Terbinafine: a pharmacological and clinical review. Expert Opin Pharmacother 10(16):2723\u20132733","journal-title":"Expert Opin Pharmacother"},{"key":"3844_CR3","volume-title":"Lamisil 250\u202fmg Tbl., Novartis Pharma N\u00fcrnberg","author":"Fachinfo","year":"2013","unstructured":"Fachinfo (2013) Lamisil 250\u202fmg Tbl., Novartis Pharma N\u00fcrnberg. http:\/\/www.fachinfo.de\/pdf\/004734 (Erstellt: September 2013) Zugriff Mai 2016"},{"issue":"11","key":"3844_CR4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203309106176","volume":"18","author":"AV Marzano","year":"2009","unstructured":"Marzano AV, Vezzoli P, Crosti C (2009) Drug-induced lupus: an update on its dermatologic aspects. Lupus 18(11):935\u2013940","journal-title":"Lupus"},{"issue":"12","key":"3844_CR5","first-page":"889","volume":"10","author":"C Dalle Vedove","year":"2012","unstructured":"Dalle Vedove C, Simon JC, Girolomoni G (2012) Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNF\u03b1 agents. J Dtsch Dermatol Ges 10(12):889\u2013897","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"3844_CR6","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1046\/j.1365-2133.1998.2576q.x","volume":"139","author":"R Brooke","year":"1998","unstructured":"Brooke R, Coulson IH, al-Dawoud A (1998) Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol 139(6):1132\u20131133","journal-title":"Br J Dermatol"},{"issue":"4","key":"3844_CR7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1365-2133.1998.02194.x","volume":"138","author":"M Murphy","year":"1998","unstructured":"Murphy M, Barnes L (1998) Terbinafine-induced lupus erythematosus. Br J Dermatol 138(4):708\u2013709","journal-title":"Br J Dermatol"},{"issue":"6","key":"3844_CR8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1365-2133.1998.2576r.x","volume":"139","author":"S Holmes","year":"1998","unstructured":"Holmes S, Kemmett D (1998) Exacerbation of systemic lupus erythematosus induced by terbinafine. Br J Dermatol 139(6):1133","journal-title":"Br J Dermatol"},{"issue":"6","key":"3844_CR9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1067\/mjd.2001.114565","volume":"44","author":"G Bonsmann","year":"2001","unstructured":"Bonsmann G, Schiller M, Luger TA, St\u00e4nder S (2001) Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 44(6):925\u2013931","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3844_CR10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1046\/j.1365-2133.2003.05235.x","volume":"148","author":"VA Hill","year":"2003","unstructured":"Hill VA, Chow J, Cowley N, Marsden RA (2003) Subacute lupus erythematosus-like eruption due to terbinafine: report of three cases. Br J Dermatol 148(5):1056","journal-title":"Br J Dermatol"},{"issue":"6","key":"3844_CR11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/00015550410018361","volume":"84","author":"DA McKay","year":"2004","unstructured":"McKay DA, Schofield OM, Benton EC (2004) Terbinafine-induced subacute cutaneous lupus erythematosus. Acta Derm Venereol 84(6):472\u2013474","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"3844_CR12","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archderm.137.9.1196","volume":"137","author":"JP Callen","year":"2001","unstructured":"Callen JP, Hughes AP, Kulp-Shorten C (2001) Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases. Arch Dermatol 137(9):1196\u20131198","journal-title":"Arch Dermatol"},{"issue":"2","key":"3844_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/rheumatology\/keh016","volume":"43","author":"G McKellar","year":"2004","unstructured":"McKellar G, Porter D, Burden D (2004) Terbinafine as a cause of cutaneous lupus erythematosus. Rheumatology (Oxford) 43(2):249","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3844_CR14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00105-004-0731-6","volume":"55","author":"T Matthes","year":"2004","unstructured":"Matthes T, Hagedorn M (2004) Terbinafine-induced subacute cutaneous lupus erythematosus. Case report and review of the literature. Hautarzt 55(7):653\u2013657","journal-title":"Hautarzt"},{"key":"3844_CR15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0151-9638(06)70941-3","volume":"133","author":"Z Terrab","year":"2006","unstructured":"Terrab Z, El Ouzzani T, Zouhair K et al (2006) Syndrome de Stevens-Johnson et aggravation d\u2019un lupus syst\u00e9mique induits par la terbinafine. Ann Dermatol 133:463\u2013466","journal-title":"Ann Dermatol"},{"issue":"1","key":"3844_CR16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000089024","volume":"212","author":"D Farhi","year":"2006","unstructured":"Farhi D, Viguier M, Cosnes A, Reygagne P, Dubertret L, Revuz J, Roujeau JC, Bachelez H (2006) Terbinafine-induced subacute cutaneous lupus erythematosus. Dermatology (Basel) 212(1):59\u201365","journal-title":"Dermatology (Basel)"},{"issue":"3","key":"3844_CR17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-4632.2004.02472.x","volume":"45","author":"P Cetkovsk\u00e1","year":"2006","unstructured":"Cetkovsk\u00e1 P, Pizinger K (2006) Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil. Int J Dermatol 45(3):320\u2013322","journal-title":"Int J Dermatol"},{"issue":"10","key":"3844_CR18","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1610-0387.2008.06806_supp.x","volume":"6","author":"K Lorentz","year":"2008","unstructured":"Lorentz K, Booken N, Goerdt S, Goebeler M (2008) Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature. J\u00a0Dtsch Dermatol Ges 6(10):823\u2013827","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"3844_CR19","first-page":"156","volume":"81","author":"CM Hivnor","year":"2008","unstructured":"Hivnor CM, Hudkins ML, Bonner B (2008) Terbinafine-induced subacute cutaneous lupus erythematosus. Cutis 81(2):156\u2013157","journal-title":"Cutis"},{"key":"3844_CR20","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1111\/j.1365-2230.2009.03380.x","volume":"34","author":"M Kasperkiewicz","year":"2009","unstructured":"Kasperkiewicz M, Anem\u00fcller W, Angelova-Fischer I et al (2009) Subacute cutaneous lupus erythematosus associated with terbinafine. Clin Exp Dermatol 34:e403\u2013e404","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"3844_CR21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00105-013-2747-2","volume":"65","author":"G Wagner","year":"2014","unstructured":"Wagner G, Sachse MM (2014) Drug-induced subacute cutaneous lupus erythematosus: repeated occurrence following treatment with terbinafine. Hautarzt 65(6):548\u2013552","journal-title":"Hautarzt"},{"issue":"2","key":"3844_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2133.2011.10397.x","volume":"165","author":"AV Marzano","year":"2011","unstructured":"Marzano AV, Lazzari R, Polloni I et al (2011) Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart. Br J Dermatol 165(2):335\u2013341","journal-title":"Br J Dermatol"},{"issue":"7","key":"3844_CR23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1365-2230.2012.04363.x","volume":"37","author":"C Champagne","year":"2012","unstructured":"Champagne C, Ratnavel R, Wong T (2012) Severe Rowell syndrome associated with oral terbinafine. Clin Exp Dermatol 37(7):822\u2013823","journal-title":"Clin Exp Dermatol"},{"key":"3844_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-210360","author":"A Murad","year":"2015","unstructured":"Murad A, Shudell E, Mulligan N (2015) Rowell\u2019s syndrome induced by terbinafine. BMJ Case Rep 2015. doi:10.1136\/bcr-2015-210360","journal-title":"BMJ Case Rep 2015"},{"issue":"4","key":"3844_CR25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5114\/pdia.2013.37038","volume":"30","author":"A Kali\u0144ska-Bienias","year":"2013","unstructured":"Kali\u0144ska-Bienias A, Kowalewski C, Wo\u017aniak K (2013) Terbinafine-induced subacute cutaneous lupus erythematosus in two patients with systemic lupus erythematosus successfully treated with topical corticosteroids. Postepy Dermatol Alergol 30(4):261\u2013264","journal-title":"Postepy Dermatol Alergol"},{"issue":"6","key":"3844_CR26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.rce.2014.04.002","volume":"214","author":"MJ Concha-Garz\u00f3n","year":"2014","unstructured":"Concha-Garz\u00f3n MJ, Solano-L\u00f3pez G, Garc\u00eda-Garc\u00eda C et al (2014) Lupus erythematosus induced by terbinafine in a patient with systemic lupus erythematosus. Rev Clin Esp 214(6):353\u2013354","journal-title":"Rev Clin Esp"},{"issue":"3","key":"3844_CR27","first-page":"465","volume":"164","author":"GC Lowe","year":"2011","unstructured":"Lowe GC, Henderson CL, Grau RH et al (2011) A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol 164(3):465\u2013472","journal-title":"Br J Dermatol"},{"issue":"2","key":"3844_CR28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","volume":"167","author":"CM Gr\u00f6nhagen","year":"2012","unstructured":"Gr\u00f6nhagen CM, Fored CM, Linder M et al (2012) Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden. Br J Dermatol 167(2):296\u2013305","journal-title":"Br J Dermatol"},{"issue":"5 Pt 2","key":"3844_CR29","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0190-9622(97)70041-0","volume":"36","author":"AK Gupta","year":"1997","unstructured":"Gupta AK, Sibbald RG, Knowles SR et al (1997) Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: four case reports and a review of drug-induced psoriasis. J Am Acad Dermatol 36(5 Pt 2):858\u2013862","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"3844_CR30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1365-4632.2010.04570.x","volume":"49","author":"KH Basavaraj","year":"2010","unstructured":"Basavaraj KH, Ashok NM, Rashmi R, Praveen TK (2010) The role of drugs in the induction and\/or exacerbation of psoriasis. Int J Dermatol 49(12):1351\u20131361","journal-title":"Int J Dermatol"},{"issue":"9","key":"3844_CR31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1365-4632.2011.05117.x","volume":"52","author":"CD Verros","year":"2013","unstructured":"Verros CD, Rallis E (2013) The role of terbinafine in induction and\/or exacerbation of psoriasis. Int J Dermatol 52(9):1155\u20131156","journal-title":"Int J Dermatol"},{"issue":"1","key":"3844_CR32","first-page":"17","volume":"11","author":"JC Szepietowski","year":"2003","unstructured":"Szepietowski JC (2003) Terbinafine exacerbates psoriasis: case report with a literature review. Acta Dermatovenerol Croat 11(1):17\u201321","journal-title":"Acta Dermatovenerol Croat"},{"issue":"5","key":"3844_CR33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/000155599750010364","volume":"79","author":"P Pauluzzi","year":"1999","unstructured":"Pauluzzi P, Boccucci N (1999) Inverse psoriasis induced by terbinafine. Acta Derm Venereol 79(5):389","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"3844_CR34","first-page":"279","volume":"127","author":"T Le Guyadec","year":"2000","unstructured":"Le Guyadec T, Saint-Blancard P, Bosonnet S et al (2000) Oral terbinafine-induced plantar pustular psoriasis. Ann Dermatol Venereol 127(3):279\u2013281","journal-title":"Ann Dermatol Venereol"},{"key":"3844_CR35","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1365-2133.2007.08184.x","volume":"157","author":"F Nishiwaki","year":"2007","unstructured":"Nishiwaki F, Matsumura Y, Morita N et\u00a0al (2007) Acrodermatitis continua of Hallopeau due to oral terbinafine. Br J Dermatol 157:1073\u20131074","journal-title":"Br J Dermatol"},{"issue":"1","key":"3844_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0190-9622(98)70411-6","volume":"39","author":"CA Papa","year":"1998","unstructured":"Papa CA, Miller OF (1998) Pustular psoriasiform eruption with leukocytosis associated with terbinafine. J\u00a0Am Acad Dermatol 39(1):115\u2013117","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3844_CR37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1365-2133.1998.02348.x","volume":"139","author":"NJ Wilson","year":"1998","unstructured":"Wilson NJ, Evans S (1998) Severe pustular psoriasis provoked by oral terbinafine. Br J Dermatol 139(1):168","journal-title":"Br J Dermatol"},{"issue":"6","key":"3844_CR38","first-page":"725","volume":"18","author":"Y Tokuyama","year":"2008","unstructured":"Tokuyama Y, Senoh A, Setsu N, Iwatsuki K (2008) Pustular psoriasis induced by terbinafine: differential diagnosis from acute generalized exanthematous pustulosis. Eur J Dermatol 18(6):725\u2013726","journal-title":"Eur J Dermatol"},{"issue":"1","key":"3844_CR39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3346\/jkms.2007.22.1.167","volume":"22","author":"BS Kim","year":"2007","unstructured":"Kim BS, Jang HS, Jwa SW et\u00a0al (2007) Generalized pustular psoriasis and hepatic dysfunction associated with oral terbinafine therapy. J\u00a0Korean Med Sci 22(1):167\u2013169","journal-title":"J Korean Med Sci"},{"issue":"1","key":"3844_CR40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15569527.2011.607202","volume":"31","author":"G Ozturk","year":"2012","unstructured":"Ozturk G, Turk BG, Karaca N et\u00a0al (2012) Generalized pustular eruptions due to terbinafine. Cutan Ocul Toxicol 31(1):81\u201384","journal-title":"Cutan Ocul Toxicol"},{"issue":"5","key":"3844_CR41","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00105-013-2698-7","volume":"65","author":"A Sidoroff","year":"2014","unstructured":"Sidoroff A (2014) Acute generalized exanthematous pustulosis. Hautarzt 65(5):430\u2013435","journal-title":"Hautarzt"},{"key":"3844_CR42","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2133.2005.06393.x","volume":"152","author":"HS Beltraminelli","year":"2005","unstructured":"Beltraminelli HS, Lerch M, Arnold A et\u00a0al (2005) Acute generalized exanthematous pustolosis induced by the anti fungal terbinafine: case report and review of the literature. Br J Dermatol 152:780\u2013783","journal-title":"Br J Dermatol"},{"issue":"2","key":"3844_CR43","first-page":"151","volume":"143","author":"P Rubegni","year":"2008","unstructured":"Rubegni P, Mandato F, Sbano P, Fimiani M (2008) Terbinafine-induced acute generalized exanthematous pustulosis. G Ital Dermatol Venereol 143(2):151\u2013155","journal-title":"G Ital Dermatol Venereol"},{"issue":"5","key":"3844_CR44","first-page":"638","volume":"20","author":"N Coquart","year":"2010","unstructured":"Coquart N, Kupfer-Bessaguet I, Staroz F, Plantin P (2010) Acute generalized exanthematous pustulosis (AGEP) induced by terbinafine and two different antibiotics: four recurrences. Eur J Dermatol 20(5):638\u2013639","journal-title":"Eur J Dermatol"},{"issue":"11","key":"3844_CR45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D38CR0T2KH","volume":"18","author":"JT Eyler","year":"2012","unstructured":"Eyler JT, Squires S, Fraga GR et\u00a0al (2012) Two cases of acute generalized exanthematous pustulosis related to oral terbinafine and an analysis of the clinical reaction pattern. Dermatol Online J 18(11):5","journal-title":"Dermatol Online J"},{"issue":"5","key":"3844_CR46","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","volume":"157","author":"A Sidoroff","year":"2007","unstructured":"Sidoroff A, Dunant A, Viboud C et al (2007) Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol 157(5):989\u2013996","journal-title":"Br J Dermatol"},{"issue":"1","key":"3844_CR47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2230.2011.04129.x","volume":"37","author":"L Duckworth","year":"2012","unstructured":"Duckworth L, Maheshwari MB, Thomson MA (2012) A diagnostic challenge: acute generalized exanthematous pustulosis or pustular psoriasis due to terbinafine. Clin Exp Dermatol 37(1):24\u201327","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"3844_CR48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A et al (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 128(1):35\u201344","journal-title":"J Invest Dermatol"},{"key":"3844_CR49","unstructured":"Leitlinie \u201eTinea freien Haut\u201c \u2013 derzeit in \u00dcberarbeitung. http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/013-002.html Zugriff Mai 2016"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3844-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-016-3844-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3844-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T19:12:12Z","timestamp":1656875532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-016-3844-9"}},"subtitle":["Medikamenteninduzierter Lupus erythematodes und Triggerung psoriatischer Hautver\u00e4nderungen","Drug-induced lupus erythematodes and triggering of psoriatic skin lesions"],"short-title":[],"issued":{"date-parts":[[2016,7,25]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["3844"],"URL":"https:\/\/doi.org\/10.1007\/s00105-016-3844-9","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,25]]}}}